Clinical Trial Update: Comparison of Effectiveness of Ranolazine Plus Metoprolol Combination vs. FlecainidE pluS Metoprolol Combination in ATrial Fibrillation Recurrences FOllowing PhaRmacological or Electrical CardioverSion of AtRial Fibrillation [Phase 2, Phase 3]

View source ↗

Summary

A trial comparing ranolazine plus metoprolol versus flecainide plus metoprolol for recurrent atrial fibrillation after cardioversion was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation

Drugs mentioned

• METOPROLOL (METOPROLOL TARTRATE)
• Ranolazine (ranolazine)
• flecainide (flecainide)

Snippet

Sponsor: Elpen Pharmaceutical Co. Inc. | Conditions: Atrial Fibrillation, Recurrence | Phase 2, Phase 3 | Status: WITHDRAWN